SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $559,000 | +45.2% | 5,060 | -1.5% | 0.18% | +47.9% |
| Q2 2022 | $385,000 | -60.4% | 5,135 | -59.0% | 0.12% | -55.3% |
| Q2 2021 | $973,000 | +13.4% | 12,517 | +8.7% | 0.27% | +10.4% |
| Q1 2021 | $858,000 | -49.4% | 11,517 | +15.8% | 0.24% | -52.5% |
| Q4 2020 | $1,695,000 | -70.0% | 9,942 | -75.3% | 0.51% | -71.8% |
| Q3 2020 | $5,643,000 | +72.2% | 40,181 | +96.6% | 1.80% | +57.0% |
| Q2 2020 | $3,277,000 | +192.9% | 20,442 | +78.7% | 1.14% | +145.5% |
| Q1 2020 | $1,119,000 | -41.2% | 11,442 | -22.4% | 0.47% | -31.8% |
| Q4 2019 | $1,902,000 | +71.4% | 14,742 | 0.0% | 0.68% | +60.7% |
| Q3 2019 | $1,110,000 | -1.1% | 14,742 | +98.1% | 0.42% | -7.0% |
| Q2 2019 | $1,122,000 | +26.5% | 7,442 | 0.0% | 0.46% | +19.3% |
| Q1 2019 | $887,000 | +9.2% | 7,442 | 0.0% | 0.38% | -5.2% |
| Q4 2018 | $812,000 | – | 7,442 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |